Home › Stocks › EBAC

EBAC — EUROPEAN BIOTECH ACQUTN CORP

Reported value held$18.72M
Funds holding (latest)7
Sector—

EBAC (EUROPEAN BIOTECH ACQUTN CORP) is tracked on HoldingsHub across five years of quarterly 13F filings. 7 funds have reported positions historically, with the sum of their latest reported stakes valued at $18.72M. No fund in our coverage reported a position in the latest filing period, which typically means the stock has fallen out of the tracked funds' portfolios rather than that it cannot be bought.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.

FundQuarterSharesValuePortfolio WeightChange
Citadel Advisors history Q1 2022 625.92K $6.10M 0.00% Hold
Marshall Wace history Q4 2022 453.99K $4.59M 0.01% Hold
D. E. Shaw & Co history Q4 2022 408.57K $4.13M 0.01% Add
Bank of America Corp history Q4 2022 260.00K $2.63M 0.00% Hold
Moore Capital Management history Q4 2022 125.00K $1.26M 0.03% Hold
UBS Group AG history Q4 2022 1.54K $15.52K 0.00% Hold
Millennium Management history Q4 2022 593.02K $5.99K 0.00% Reduce

New Positions (latest)

No fund opened a new position this quarter.

Fully Exited (vs previous quarter)

No tracked fund fully exited this quarter.

Fund Position History — shares by quarter (top 7 funds)

FundQ3 2021Q4 2021Q1 2022Q2 2022Q3 2022Q4 2022
Marshall Wace 325.75K 413.71K 437.09K 437.09K 453.99K 453.99K
D. E. Shaw & Co 229.03K 394.16K 258.17K 258.17K 258.57K 408.57K
Bank of America Corp — — 260.00K 260.00K 260.00K 260.00K
Moore Capital Management 125.00K 125.00K 125.00K 125.00K 125.00K 125.00K
UBS Group AG 169 169 1.54K 1.54K 1.54K 1.54K
Millennium Management 143.48K 134.47K 599.13K 596.57K 596.57K 593.02K
Citadel Advisors 625.75K 625.89K 625.92K — — —

Download holders (CSV)